Cancer Control: Journal of the Moffitt Cancer Center is published by H. Lee Moffitt Cancer Center & Research Institute, 12902 Magnolia Drive, Tampa, FL 33612. Telephone: (813) 745-1349. Fax: (813) 745-4950. Email: firstname.lastname@example.org. Cancer Control is included in Index Medicus/MEDLINE and EMBASE/Excerpta Medica.
All articles published, including editorials and letters, represent the opinions of the authors and do not reflect the opinions of the editorial board, the H. Lee Moffitt Cancer Center & Research Institute, Inc., or the institution with which the author is affiliated, unless clearly specified. The reader is advised to independently verify the effectiveness of all methods of treatment and the accuracy of all drug names, dosages, and schedules. Dosages and methods of administration of pharmaceutical products may not be those listed in the package insert and solely reflect the experience of the author(s) and/or clinical investigator(s)
This peer-reviewed journal contains articles on the spectrum of actions and approaches needed to reduce the impact of human malignancy.
Cancer Control is sent at no charge to about 13,000 medical professionals, including oncologists in all subspecialties; selected primary care physicians; medical researchers who specialize in oncology; and others who have a professional interest in cancer control.
Original articles are included in each issue, along with a listing of relevant clinical research protocols. Previously unpublished articles on any aspect of oncologic practice as it relates to cancer control are invited from readers and will be considered for publication by the editorial board.
Copyright by H. Lee Moffitt Cancer Center & Research Institute. All rights reserved.